Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas

BACKGROUND: Advanced biliary tract carcinomas (BTCs) have poor prognosis and limited therapeutic options. Therefore, it is crucial to combine standard therapies with molecular targeting. In this study EGFR, HER2, and their molecular transducers were analysed in terms of mutations, amplifications and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pignochino, Ymera, Sarotto, Ivana, Peraldo-Neia, Caterina, Penachioni, Junia Y, Cavalloni, Giuliana, Migliardi, Giorgia, Casorzo, Laura, Chiorino, Giovanna, Risio, Mauro, Bardelli, Alberto, Aglietta, Massimo, Leone, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2010
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3000850/
https://ncbi.nlm.nih.gov/pubmed/21087480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-631
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados